Lofgren syndrome represents an acute, clinically distinct presentation of systemic sarcoidosis characterized by a classic constellation of clinical findings: bilateral hilar lymphadenopathy (BHL) on chest imaging, tender subcutaneous nodules of erythema nodosum, and acute migratory polyarthritis predominantly affecting the ankles 2,6. First described comprehensively by the Swedish physician Sven Löfgren, this syndrome accounts for a substantial proportion of acute sarcoidosis presentations, particularly among individuals of Scandinavian, Irish, and Caucasian descent 6. Unlike chronic forms of sarcoidosis, Lofgren syndrome is strongly associated with specific genetic markers, most notably the human leukocyte antigen (HLA)-DRB1*03 allele, which heralds a remarkably favorable prognosis characterized by high rates of spontaneous, complete disease remission within 18 to 24 months 3,6. Understanding the distinct immunological pathways, accurate diagnostic criteria, and conservative management strategies is vital for clinicians to prevent misdiagnosis and avoid unnecessary invasive interventions.

Etiology & Risk Factors

  • Genetic Predisposition: Strongly linked to the human leukocyte antigen HLA-DRB1*03 allele (and extended ancestral haplotypes including HLA-A1, B8, DR3) in Caucasian populations, conferring both the acute clinical phenotype and a high likelihood of spontaneous remission 3,6.
  • Genetic Variants: Specific polymorphisms, such as the ANXA11 rs1049550 gene variant, show significant associations with susceptibility to Löfgren syndrome versus chronic progressive sarcoidosis phenotypes 1.
  • Environmental and Infectious Triggers: Presumed to be initiated by an exaggerated T-cell-mediated immune response to unidentified airborne environmental antigens, occupational exposures, or microbial triggers (such as mycobacterial or propionibacterial antigens) in genetically vulnerable hosts 4.
  • Demographic Factors: Most frequently diagnosed in young adults aged 20 to 40 years, with a notable female predominance in most Western cohorts, and highest baseline incidence rates observed in Nordic, Swedish, and Irish populations 6.

Pathophysiology

The pathophysiological hallmark of Lofgren syndrome involves a brisk, self-limited, cell-mediated immune response directed against an unmasked or inhaled antigen 4. Presentation of the antigen by alveolar macrophages and dendritic cells to CD4+ T-helper lymphocytes drives a vigorous Th1 and Th17 polarization within affected tissues 5. Interleukin-2 (IL-2), interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α) are secreted in high quantities, recruiting mononuclear phagocytes that aggregate to form compact, non-caseating epithelioid cell granulomas 6. In Lofgren syndrome, the immune profile features a balanced or regulatory cytokine network within bronchoalveolar lavage fluid (BALF), contrasting with the destructive Th1.7-driven fibrotic cascades seen in chronic progressive sarcoidosis 5. Concurrently, immune complex deposition and local inflammatory mediator release within the dermal subcutaneous fat and synovial membranes precipitate the characteristic cutaneous vasculitis of erythema nodosum and the sterile immune-mediated synovitis of the ankles 2,6.

Lofgren syndrome — Pathophysiological Cascade & Clinical Flowchart 1 Trigger / Primary Insult Exposure to environmental or infectious antigens in genetically susceptible hosts (HLA-DRB1*03) 2 Cellular / Pathophysiological Cascade Antogenic presentation by alveolar macrophages driving Th1 and Th17 immune polarization 3 Target Organ / Structural Change Granuloma formation within mediastinal/hilar lymph nodes, dermis, and synovial tissues 4 Hallmark Clinical & Diagnostic Manifestation Acute onset of bilateral hilar lymphadenopathy, erythema nodosum, and painful ankle arthritis 5 Complications if Untreated & Therapeutic Target Persistent joint inflammation or chronic progression managed via NSAIDs or short-course corticosteroids

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients typically present with an abrupt, acute onset (often over days to a few weeks) of systemic symptoms including low-grade fevers, malaise, fatigue, arthralgias, and the classic triad of bilateral ankle swelling, painful pretibial nodules, and respiratory symptoms (such as a dry, non-productive cough or mild retrosternal chest discomfort) 2,6,7.
  • Physical Examination & Named Clinical Signs:
    • Erythema Nodosum: Tender, bright red to violaceous subcutaneous nodules located symmetrically on the anterior shins; these lesions heal without ulceration, often evolving through a bruise-like color transition (panniculitis).
    • Ankle Polyarthritis / Periarthritis: Marked, painful periarticular soft tissue swelling and tender joint effusions predominantly localized to the ankles and dorsum of the feet, frequently accompanied by marked functional immobility. Despite severe pain and warmth, true joint destruction or erosions do not occur.
    • Lymphadenopathy: Peripheral lymphadenopathy (cervical, axillary, or epitrochlear) may occasionally be palpated, though hepatosplenomegaly is less common in acute presentations compared to chronic variants.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationEndobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) demonstrating compact, non-caseating epithelioid cell granulomas with multinucleated giant cells and negative stains for acid-fast bacilli and fungi.
Laboratory PanelElevated serum angiotensin-converting enzyme (ACE) levels (though normal in up to 40% of acute cases), elevated inflammatory markers (erythrocyte sedimentation rate [ESR] and C-reactive protein [CRP]), hypercalciuria (due to ectopic 1-alpha-hydroxylase activity in macrophages), and mild peripheral lymphopenia.
Imaging / Radiology (X-ray, US, CT, MRI)Chest radiography demonstrating classic symmetric bilateral hilar lymphadenopathy (often accompanied by right paratracheal lymph node enlargement), characteristic of Scadding Stage I. High-resolution computed tomography (HRCT) confirms bulky mediastinal and hilar adenopathy without parenchymal honeycombing or traction bronchiectasis.
ECG / Histopathology / Procedural12-lead electrocardiogram (to screen for asymptomatic cardiac involvement or conduction blocks). Skin biopsy of an erythema nodosum lesion demonstrates septal panniculitis without primary vasculitis. Bronchoalveolar lavage (BAL) reveals marked lymphocytic alveolitis with an elevated CD4/CD8 ratio greater than 3.5.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Scadding Stage IBilateral hilar lymphadenopathy alone; observed in the vast majority of Lofgren syndrome presentations, carrying a greater than 80% to 90% chance of spontaneous complete resolution.
Scadding Stage IIBilateral hilar lymphadenopathy combined with pulmonary parenchymal infiltration; may occasionally be observed in acute presentations, requiring closer serial pulmonary function monitoring.
HLA-DRB1*03 GenotypingPresence of the HLA-DR3 allele serves as a genetic prognostic marker strongly correlating with acute onset, complete symptomatic recovery, and freedom from chronic fibrotic progression.

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Tuberculosis (Primary Pulmonary TB)Presents with asymmetric hilar lymphadenopathy, lower or upper lobe cavitary infiltrates, positive sputum acid-fast bacilli smear or culture, and caseating granulomas on biopsy.
Lymphoma (Hodgkin or Non-Hodgkin)Features asymmetric, bulky mediastinal lymphadenopathy, constitutional B symptoms (drenching night sweats, profound weight loss), hepatosplenomegaly, and absence of erythema nodosum and acute ankle arthritis.
Streptococcal / Post-Infectious Erythema NodosumAssociated with recent upper respiratory tract infections or streptolysin O titer elevations, lacking the symmetric bilateral hilar adenopathy and distinct CD4/CD8 lymphocytic alveolitis pattern seen in sarcoidosis.
Inflammatory Bowel Disease-Associated ArthropathyPresents with asymmetrical peripheral arthritis or axial spondyloarthritis accompanied by chronic gastrointestinal symptoms (bloody diarrhea, abdominal cramping), without bilateral hilar adenopathy.

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Assess respiratory status and rule out acute hypercalcemia or cardiac conduction abnormalities. Provide patient reassurance regarding the self-limiting nature of the condition and the high probability of full spontaneous recovery.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing):
    • Supportive Care: Bed rest, limb elevation, and cool compresses for erythema nodosum.
    • Analgesia & Anti-inflammatory Agents: Scheduled non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen 400 to 600 mg orally every 8 hours or naproxen 500 mg orally twice daily with food, administered alongside a proton pump inhibitor for gastric mucosal protection, effectively manage joint pain and cutaneous tenderness.
    • Corticosteroid Protocol (for refractory symptoms): Reserved for patients with debilitating polyarthritis unresponsive to NSAIDs, severe systemic constitutional symptoms, or persistent organ dysfunction. Initiate prednisolone 20 to 40 mg orally once daily, followed by a gradual taper over 6 to 12 weeks.
  • Surgical / Interventional Indications: Diagnostic tissue acquisition via EBUS-TBNA or superficial skin punch biopsy is performed when atypical features raise suspicion for malignancy or infection; surgical intervention is otherwise not indicated.

Complications & Prognosis

  • Prognosis: Exceptionally favorable compared to non-Löfgren sarcoidosis phenotypes. Spontaneous clinical and radiological remission occurs in over 80% to 90% of cases within 1 to 2 years, with minimal risk of progression to pulmonary fibrosis 3,6.
  • Acute Complications: Severe functional limitation secondary to acute ankle periarthritis, transient hypercalcemia, and rare uveitis flares requiring ophthalmologic evaluation.
  • Chronic Complications: A small subset of patients may experience a protracted or relapsing course (particularly in non-Caucasian or non-HLA-DR3 cohorts), occasionally progressing to chronic pulmonary sarcoidosis requiring second-line steroid-sparing immunosuppressants (e.g., methotrexate) 7.